DONNA PERSON: Open Payments
NPI 1740754126 · FLORISSANT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,341 in 12 payments from 8 companies in 2025. Trend: 2023 $1,110 · 2024 $862 · 2025 $1,341
Food & beverage: $1,341
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $378 |
| Novo Nordisk Inc | 2 | $247 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $220 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $116 |
| Dexcom, Inc. | 1 | $110 |
| Lilly USA, LLC | 1 | $110 |
| Exact Sciences Corporation | 1 | $35 |
Products named: BREZTRI, Wegovy, JARDIANCE, Auvelity, AIRSUPRA, AREXVY, DEXCOM G7 GSS (161), MOUNJARO.
Industry payments across MO — which companies pay providers there.
